(Q62818676)

English

Safety and Tolerability of LEO 138559 in Healthy Subjects and Subjects With Atopic Dermatitis

clinical trial

Statements

Randomised, Double-blind, Placebo-controlled, Single and Multiple Ascending Dose Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEO 138559 in Healthy Subjects and Subjects With Moderate to Severe Atopic Dermatitis (English)
0 references
0 references
0 references
0 references
7 May 2018
0 references
October 2019
0 references
54
0 references
18 year
0 references
55 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit